Neuronetics Inc. (STIM)
STIM trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1227636/000110465926029004/0001104659-26-029004-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | STIM on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001227636 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $149.2M |
| Net income | -$39.0M |
| Operating income | -$31.4M |
| Net margin | -26.1% |
| Operating margin | -21.1% |
| Revenue growth | +99.2% |
| Cash | $28.1M |
| Total assets | $141.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.8× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Therefore, substantial doubt exists about the Company's ability to continue as a going concern." | 10-Q 2026-11-04 |
| Cash and burn | $22.1M cash; operating cash flow -$2.1M a quarter. | Report 2026-09-30 |
| Shares outstanding | 77,728,311 (2026-10-28); 68,485,922 a year earlier; 28,933,132 three years earlier. | Cover page 2026-10-28 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the market | Latest 2026-11-12 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | KPMG LLP, Philadelphia, Pennsylvania, United States | PCAOB Form AP 2026-04-01 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $4.8M, sold $282K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $42.0M | -$1.7M | $1.2M | $22.1M | $61.8M | $159.8M | 10-Q 2026-11-04 |
| Q2 2026 2026-06-30 | $41.6M | -$3.4M | -$1.0M | $19.2M | $61.5M | $155.1M | 10-Q 2026-08-11 |
| Q1 2026 2026-03-31 | $34.5M | -$10.8M | -$9.4M | $13.2M | $61.3M | $151.6M | 10-Q 2026-05-05 |
| Q4 2025 2025-12-31 | $41.8M | -$7.2M | $882K | $28.1M | $65.8M | $149.2M | 10-K 2026-03-17 |
| Q3 2025 2025-09-30 | $37.3M | -$9.0M | -$785K | $28.0M | $65.7M | $129.9M | 10-Q 2026-11-04 |
| Q2 2025 2025-06-30 | $38.1M | -$10.1M | -$3.5M | $11.0M | $55.5M | $111.1M | 10-Q 2026-08-11 |
| Q1 2025 2025-03-31 | $32.0M | -$12.7M | -$17.0M | $20.2M | $55.3M | $89.4M | 10-Q 2026-05-05 |
| Q4 2024 2024-12-31 | $22.5M | -$12.7M | -$8.6M | $18.5M | $55.2M | $74.9M | 10-K 2026-03-17 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-11-12 |
| Latest annual report | 10-K | 2026-03-17 |
| Latest quarterly / interim | 10-Q | 2026-11-04 |
| Latest current report | 8-K/A | 2026-11-12 |
| Latest proxy | DEFA14A | 2026-04-09 |
Source: SEC EDGAR submissions feed, 729 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -35.3% |
| 1 month | -30.2% |
| 3 months | -54.1% |
| Year to date | +0.7% |
| 1 year | -31.9% |
| From 52-week high | -57.9% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LUNG | Pulmonx Corporation | $2.80 | -2.10% | $121.9M |
| PYPD | PolyPid Ltd. | $6.15 | -1.76% | $124.9M |
| APYX | Apyx Medical Corporation | $2.65 | -5.69% | $111.6M |
| SKYA | SkyAI Inc. | $2.11 | -9.05% | $107.3M |
| SKIN | SkinHealth Systems Inc. | $15.05 | -7.73% | $98.5M |
| KRMD | KORU Medical Systems Inc. Common Stock (DE) | $3.69 | -0.27% | $160.1M |
| NYXH | Nyxoah SA | $0.8937 | -0.64% | $89.4M |
| ANIK | Anika Therapeutics Inc. | $12.92 | -3.58% | $173.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier